Prof David Hunt

Professor of Neuroinflammatory Medicine at University of Edinburgh.
Wellcome Senior Clinical Fellow

[Prof David Hunt @HuntLabEdin]

Delighted that our work on interferon-alpha driven brain disease has made the front cover of @ImmunityCP after many years of work with brilliant collaborators in Australia, France and US. Short summary of paper to follow.

[Immunity @ImmunityCP]

This month's beautiful cover depicts work from Hofer, @HuntLabEdin, Viengkhou &co showing that in Aicardi-Goutières syndrome, neurotoxic IFNα originates in the CNS & mediates disease primarily through its effects on the cerebral microvasculature. Image by Ben Gartland, Grant Foster, and Holly Philip.
https://t.co/hzeeS3Toaq

[UK Dementia Research Institute @UKDRI]

Research by @HuntLabEdin & @DrMcglasson (UK DRI at Edinburgh) sheds light on the mechanisms behind RVCL-S, a rare genetic disorder that affects small blood vessels.

The study identifies an important therapeutic target�� https://t.co/GjSimnoLrq

[Anne Rowling Regenerative Neurology Clinic @AnneRowlClinic]

🧠Calling neuroimmunology/MS clinicians, scientists, ECRs & healthcare professionals.
Neuroimmunology & MS 2025 will be held in Edinburgh on 11 - 12 March 2025 & features the Belinda Weller Distinguished Lecture.
Info: https://t.co/ERRw0VPXG6
@ABNTrainees @DCNNeuro @HuntLabEdin

[Anne Rowling Regenerative Neurology Clinic @AnneRowlClinic]

There’s a wide range of topics at this year’s Neuroimmunology & MS 2025 meeting. To register, submit your abstract & to view the list of topics visit: https://t.co/ERRw0VPXG6
pls share @EdinUniNeuro @HuntLabEdin @DCNNeuro @foley_p_neuro
@EdinUniImaging
#neuroimmunology_MS_25

[UK Dementia Research Institute @UKDRI]

⭐️The UK DRI exists to transform the lives of people affected by or at risk of neurodegenerative conditions.⭐️

Our vision is ‘healthy brain🧠ageing for all’.
Our research will transform lives.
We are the UK DRI.

@The_MRC @alzheimerssoc @AlzResearchUK @lifearc1 @TheBHF @NIHRresearch

[Prof David Hunt @HuntLabEdin]

Congratulations @JensKuhle !

[RC2NB @RC2NB]

Ending the Year on a High Note!

Prof. @JensKuhle (@UniSpitalBasel) has been awarded the Sobek Foundation Award 2024, Europe’s most prestigious honor in MS research!

A remarkable recognition for his work on biomarkers transforming MS care. @UniBasel_en #MultipleSclerosis

[Anne Rowling Regenerative Neurology Clinic @AnneRowlClinic]

🗓️ Neuroimmunology & MS 2025🗓️
Registration & abstract submission is now OPEN!
We have an excellent line up of topics & guest speakers covering all things neuroimmunology & MS.
More info 👉 https://t.co/ERRw0VPXG6 #neuroimmunology_MS_25 #ExtraordinaryEdinburgh
Pls reTweet

[Prof David Hunt @HuntLabEdin]

Please RT! This was such an enjoyable event last year. Registration now open. Free registration for early careers researchers and clinicians in training who submit an abstract

[Anne Rowling Regenerative Neurology Clinic @AnneRowlClinic]

🧵1/2
Registration & abstract submission is now open for Neuroimmunology & MS 2025.  Back by popular demand this 2-day meeting is focused on neuroimmunology & MS. Numbers are limited so register now! https://t.co/ERRw0VPXG6
#neuroimmunology_MS_25 #research #education

[Prof David Hunt @HuntLabEdin]

Great work Eve

[Eve smith @evemdsmith_eve]

📣Excited to share our latest study showing:

🎯IFN-α2 levels differentiate between T2T states in cSLE

🎯Elevated IFN-α2 predictive of flare when in target

⁉️potential for biomarker-driven cSLE T2T trials

🔗 https://t.co/p14VIgT1VB

@CrowYanick @HuntLabEdin @ValentinaNatol1

[Eve smith @evemdsmith_eve]

📣Excited to share our latest study showing:

🎯IFN-α2 levels differentiate between T2T states in cSLE

🎯Elevated IFN-α2 predictive of flare when in target

⁉️potential for biomarker-driven cSLE T2T trials

🔗 https://t.co/p14VIgT1VB

@CrowYanick @HuntLabEdin @ValentinaNatol1

[Prof David Hunt @HuntLabEdin]

@suvankarpal @EdinburghUni Congratulations Suvankar!

[Prof David Hunt @HuntLabEdin]

This meeting was a great success last year and we had lots of requests to repeat it. Save the date if you are interested in the cutting edge of neuroimmunology and MS. More information soon, please circulate

[Anne Rowling Regenerative Neurology Clinic @AnneRowlClinic]

🗓️Save the date!
We're pleased to announce that Neuroimmunology & MS 2025 research & academic meeting will be held in Edinburgh on 11 - 12th Mar 25.
Registration & call for abstracts opening soon!
For more info visit our website https://t.co/ERRw0VPXG6
#neuroimmunology_MS_25

[Dr Niall MacDougall @dr_niall]

Maybe the best poster at #ECTRIMS2024 ? EBV latent viral load predicting disease activity in MS

Lots of interest @kearnsneuro @HuntLabEdin @foley_p_neuro @AnneRowlClinic

[Trends in Neurosciences @TrendsNeuro]

'Unweaving type I interferons in age-related neuroinflammation'

@TrendsNeuro Spotlight by David Hunt & Markus Hofer
https://t.co/E0bquepLIz

discussing Roy et al. 2024, @MolNeuro, @WeiCao_PhD group
https://t.co/W9snsX5PKs

[Prof David Hunt @HuntLabEdin]

Work like this would struggle to go ahead without funding from the wonderful organisation that is @MedResFdn, who support vital research in underfunded areas.

[Medical Research UK @mruk_charity]

Aicardi-Goutieres syndrome is a rare disease that can trigger #dementia in children.

Previous Emerging Leaders Prize winner @HuntLabEdin recently co-led a study, funded in part by @MedResFdn, that could lead to new treatments for this condition.

https://t.co/b1eWt6ynpM @UKDRI

[OLNI @OxLabNeuroImm]

Introducing, Oxford Laboratory for Neuroimmunology and Immunopsychiatry (OLNI)! We are a group of clinicians and scientists who want to understand how inflammation affects the brain.

@Annapoorna2024 @tomj_14 @handunnetthi @babakneuro @Greg__Holt @LaurissaJoy

Watch this space!

[Prof David Hunt @HuntLabEdin]

Important review on how neurology contributes to vaccine safety. Thank you to wonderful author team and @NatRevNeurol.

Free access here: https://t.co/zQxxhMAPG1

@MedResFdn @UKDRI

[OLNI @OxLabNeuroImm]

Check out our review on rare neurological complications linked to vaccination in @NatRevNeurol.

https://t.co/ijg0aneMDQ

@OxLabNeuroImm Maheshi Ramasamy @OxfordVacGroup @LanceTurtle @HuntLabEdin

[Medical Research UK @mruk_charity]

Aicardi-Goutieres syndrome is a rare disease that can trigger #dementia in children.

Previous Emerging Leaders Prize winner @HuntLabEdin recently co-led a study, funded in part by @MedResFdn, that could lead to new treatments for this condition.

https://t.co/b1eWt6ynpM @UKDRI

[Charles Perkins Centre @CPC_usyd]

Promising pathway discovered to treat rare childhood brain disease

A study co-led by @Sydney_Uni + @CPC_usyd Assoc Prof Markus Hofer + Prof @HuntLabEdin reveals fresh insight into the mechanisms underlying a rare disease that can cause childhood dementia Aicardi-Goutières syndrome.

The research, featured on the front cover of the journal Immunity @CellPressNews, could lead to urgently needed new therapeutic targets for the condition.

Read the story 🧠 ➡️ https://t.co/MLSuCJnSEH

[Prof David Hunt @HuntLabEdin]

Delighted that our work on interferon-alpha driven brain disease has made the front cover of @ImmunityCP after many years of work with brilliant collaborators in Australia, France and US. Short summary of paper to follow.

[Prof David Hunt @HuntLabEdin]

@darragh_duffy @crow_lab @Mayo_AING @UKDRI @EdinUniNeuro @ward6aus @KatieEmelianova @DrMcglasson @wellcometrust

[Prof David Hunt @HuntLabEdin]

Delighted that our work on interferon-alpha driven brain disease has made the front cover of @ImmunityCP after many years of work with brilliant collaborators in Australia, France and US. Short summary of paper to follow.

[Immunity @ImmunityCP]

This month's beautiful cover depicts work from Hofer, @HuntLabEdin, Viengkhou &co showing that in Aicardi-Goutières syndrome, neurotoxic IFNα originates in the CNS & mediates disease primarily through its effects on the cerebral microvasculature. Image by Ben Gartland, Grant Foster, and Holly Philip.
https://t.co/hzeeS3Toaq